J&J
J&J hit by another string of product recalls
February 21, 2011Manufacturing and Production J&J, JJ, Johnson & Johnson, Simponi, golimumab, manufacturing compliance, pharma recalls
There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …
J&J posts negative growth as pharma sales stall
January 26, 2011Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta
Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …
Congressman says FDA should scrutinise J&J’s manufacturing partners
December 21, 2010Manufacturing and Production BestSweet, FDA, J&J, JJ, Johnson & Johnson, McNeil, Rolaids, manufacturing compliance, recalls
The latest flurry of recalls from Johnson & Johnson has prompted additional calls for a wide-ranging investigation of the company’s …
McNeil recalls Rolaids on particle contamination
December 14, 2010Manufacturing and Production J&J, JJ, McNeil, Rolaids, particulate contamination, pharmaceutical manufacturing, product recalls
Recalls at Johnson & Johnson are coming thick and fast at the moment. In the latest incident the firm’s troubled …
Millions more OTC products recalled by J&J
November 29, 2010Manufacturing and Production Benadryl Allergy Fastmelt, J&J, JJ, Johnson & Johnson, Motrin, Rolaids, Tylenol, manufacturing compliance, recalls
Johnson & Johnson has been forced to announce yet another recall of over-the-counter medicines manufactured at its Fort Washington facility …
J&J and Takeda issue recall for cancer drug Velcade
November 22, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls
Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …
Johnson & Johnson recalls more Tylenol
October 21, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, Tylenol, pharma recalls, product recalls
Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …
Alzheimer’s disease
October 16, 2010Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Elan, J&J, JJ, Pfizer, lilly, pharmaceutical
In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …
Pepscan and Tibotec sign peptides deal
September 15, 2010Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec
Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …
J&J chalks up ninth product recall in 2010
August 26, 2010Manufacturing and Production J&J, JJ
Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …
J&J appoints quality tsar to oversee manufacturing revamp
August 24, 2010Manufacturing and Production J&J, JJ, recalls
Johnson & Johnson plans to beef up senior management across its three business units as part of a broader programme …
J&J post modest second quarter increase
July 21, 2010Sales and Marketing 2010 financials, J&J, JJ, Q2
Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …
J&J cited by FDA for another manufacturing facility
July 20, 2010Manufacturing and Production J&J, JJ, manufacturing compliance
Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …
J&J faces FDA scrutiny for another manufacturing unit
May 27, 2010Manufacturing and Production Advanced Sterilization Products, Ethicon, J&J, JJ, McNeil, manufacturing compliance
Another Johnson & Johnson subsidiary has come under scrutiny by FDA for failing to meet quality standards in its manufacturing. …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
